Galectin Therapeutics shares owned by Cambridge Investment Research Advisors
Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Cambridge Investment Research Advisors
from 13F filings
Historical chart of Cambridge Investment Research Advisors investment in Galectin Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Galectin Therapeutics held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Galectin Therapeutics by Cambridge Investment Research Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $315k | 115k | 2.75 |
| 2024-06-30 | $253k | 112k | 2.26 |
| 2024-03-31 | $290k | 121k | 2.39 |
| 2023-12-31 | $210k | 127k | 1.66 |
| 2023-09-30 | $265k | 138k | 1.92 |
| 2023-06-30 | $193k | 134k | 1.44 |
| 2023-03-31 | $299k | 142k | 2.10 |
| 2022-12-31 | $171k | 152k | 1.13 |
| 2022-09-30 | $246k | 151k | 1.63 |
| 2022-06-30 | $195k | 149k | 1.31 |
| 2022-03-31 | $234k | 145k | 1.61 |
| 2021-12-31 | $317k | 153k | 2.07 |
| 2021-09-30 | $638k | 165k | 3.88 |
| 2021-06-30 | $539k | 168k | 3.20 |
| 2020-12-31 | $402k | 180k | 2.24 |
| 2020-09-30 | $510k | 191k | 2.67 |
| 2020-06-30 | $621k | 203k | 3.06 |
| 2020-03-31 | $401k | 205k | 1.96 |
| 2019-12-31 | $545k | 191k | 2.86 |
| 2019-09-30 | $965k | 233k | 4.15 |
| 2019-06-30 | $965k | 233k | 4.15 |
| 2019-03-31 | $901k | 176k | 5.11 |
More positions owned by Cambridge Investment Research Advisors
View all positions for Cambridge Investment Research Advisors